The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Filsuvez



Amryt Pharmaceuticals DAC,EU/1/22/1652/001-002

Main Information

Trade NameFilsuvez
Active SubstancesBETULAE CORTEX DRY EXTRACT (5-10 : 1); EXTRACTION SOLVENT: N-HEPTANE 95% (W/W)
Dosage FormGel
Licence HolderAmryt Pharmaceuticals DAC,
Licence NumberEU/1/22/1652/001-002

Group Information

ATC CodeD03AX Other cicatrizants
D03AX13 Betulae cortex

Status

License statusAuthorised
Licence Issued21/06/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back